US FDA unveils new Plant and Animal Biotechnology Innovation Action Plan

2018-10-31 10:59:45

This new plan advances policy priorities that the US FDA will pursue to clarify its science-and-risk-based approach for product developers; avoid unnecessary barriers to future innovation; and advance safety and public health mission. By Team ABLEOn October 30, 2018, a statement on the FDA’s new plan to advance plant and animal biotechnology innovations was released by the US FDA Commission

Read more

Lilly,Dicernasign RNAi licensing and research collaboration

2018-10-30 09:21:50

The companies will utilize Dicerna\'s proprietary GalXC RNAi technology platform to progress new drug targets toward clinical development and commercialization.By Team ABLEEli Lilly and CompanyandDicerna Pharmaceuticals have inked a global licensing and research collaboration focused on the discovery, development and commercialization of potential new medicines in the areas of cardio-metabolic dis

Read more

Novartis Pfizer collaborate to advance NASH therapeutics

2018-10-30 09:20:54

Novartis recently entered into a clinical development agreement with Pfizer, which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH. By Team ABLENovartis recently entered into a clinical development agreement with Pfizer, which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an

Read more

Abbott’s latest Influenza, Strep POC assays to offer super quick diagnosis

2018-10-29 09:02:05

Abbott has announced that the new assays enable the fastest-ever time to molecular influenza A & B and Strep A results at the point of care.By Team ABLEAbbott has announced recently that the U.S. Food and Drug Administration (FDA) has cleared its next-generation Influenza A & B 2 and Strep A 2 molecular assays for point-of-care testing. These new assays are claimed to enable the fastest-ev

Read more

UK Research and Innovation India launched to accelerate mutual R&D collaborations

2018-10-29 09:01:19

UKRI India is a new body that partners with universities, research organizations, and government funding agencies to create the best possible environment for research and innovation to flourish.By Team ABLERecently, on October 25th, an event was organized in New Delhi to celebrate the successes of a decade-long Indo-UK collaboration in research and innovation, and to mark the launch of the UK Rese

Read more

Japanese companies Mitsui, Chitose launch Open Innovation Initiative to foster businesses and talents

2018-10-29 09:00:42

Mitsui Chemicals Inc and Chitose Group, a group of biotechnology startups, have jointly launched the \"0 to 1 Project\" as a novel open innovation initiative to foster \"business and talents” based on their unique technologies. By Team ABLEMitsui Chemicals Inc and Chitose Group, a group of biotechnology startups, have jointly launched the \"0 to 1 Project\" as a novel open innovation initia

Read more

Johnson & Johnson unveils new vaccines launch facility to support global rollout of novel vaccines

2018-10-29 09:00:01

The new facility in Leiden, the Netherlands has been built by Janssen Vaccines & Prevention B.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson.By Team ABLEJohnson & Johnson recently unveiled its new vaccines launch facility that represents a significant investment by the company in novel vaccines development, global health and security, and pandemic preparedness ef

Read more

Ginkgo Bioworksopens Bioworks4; adds new tools for rapid genetic engineering of mammalian cells

2018-10-26 10:04:37

The newest foundry catalyzes synthetic biology for pharmaceutical applications, empowering accessible and scalable R&D for therapeuticsBy Team ABLEGinkgo Bioworks, the organism company, has announced the opening of Bioworks4, its latest biological engineering foundry. With this fourth foundry, Ginkgo expands its footprint to nearly 100,000 square feet dedicated to designing and printing DNA an

Read more

ShanIPV receives WHO prequalification status

2018-10-26 09:59:53

This status qualifies ShanIPV vaccine for purchase by the United Nations agencies.By Team ABLESanofi Pasteur, the vaccines division of Sanofi, has announced that its standalone IPV (Inactivated Polio Vaccine) ShanIPV, developed by its India-based affiliate Shantha Biotechnics,has received prequalification status from the World Health Organization (WHO). This status qualifies ShanIPV vaccine for pu

Read more

Biotech startup Clensta International raises seed fund

2018-10-26 09:57:48

Clensta International has raised an undisclosed amount of funds in seed funding from Indian Angel Network (IAN) and its maiden venture capital fund IAN Fund. By Team ABLENew Delhi-based biotech startup Clensta International has raised an undisclosed amount of funds in seed funding from Indian Angel Network (IAN)and its maiden venture capital fund IAN Fund.The round was led by IAN members, Ris

Read more